Specialty Area
Spotlight
Topics
Institute for Value-Based Medicine
About AJMC
Podcasts
CE
Subscribe
- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Biosimilars Unveiled: Current Trends, Challenges, and Future Opportunities in the US Marketplace : Episode 5
Navigating Biosimilar Uptake in New Patients
The panel discuss if including biosimilars on formulary at parity is enough to support their adoption.
EP: 1.Biologics Utilization Impacting US Health Care Spending
EP: 2.Current Landscape of Biosimilar Use in US Healthcare Space
EP: 3.Interchangeability Impacting Biosimilar Uptake
EP: 4.The Impact of Payer Coverage and Reimbursement on Biosimilars
Now Viewing
EP: 5.Navigating Biosimilar Uptake in New Patients
EP: 6.Economic Impacts and Pricing Strategies Surrounding Biosimilars
EP: 7.Private Label Biosimilars
EP: 8.Biosimilars in the Commercial Sector
EP: 9.The Influence of Employer Preferences And Adoption of Biosimilars
EP: 10.Out of Pocket Costs Associated with Biosimilar Use
EP: 11.Unmet Needs and Future Initiatives
EP: 12.Ideal Goals for Biosimilar Utilization
EP: 13.Foreseeable Biosimilar Trends
EP: 14.Legislative Support for Biosimilars
EP: 15.Key Takeaways for Biosimilar Utilization
Video content above is prompted by the following:
- How do you direct new-start patients to a biosimilar? What about switching?
- Payers require generic medications over brand name in most instances. Why isn’t this the case for biosimilars?
Related Videos
